Guastella 2006.

Trial name or title	The role of D‐Cycloserine in combination with exposure therapy in the treatment of Panic Disorder to improve the severity of Panic Symptoms
Methods	Randomised parallel controlled trial
Participants	Subjects aged 18 years and older with a primary diagnosis of panic disorder
Interventions	DCS and exposure therapy. Participants receive 3 weekly sessions of group‐based exposure therapy. One group of participants receives 50 mg of DCS before each session
Outcomes	Severity of panic symptoms: global functioning such as their general health, depression and stress levels and current diagnosis
Starting date	June 2006
Contact information	a.guastella@unsw.edu.au
Notes	Study ID: ACTRN12606000351516